Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Tamayo, Esther ^a   Montes, Milagrosa ^a,b   García Medina, Guadalupe ^b   García Arenzana, José M ^b   Pérez Trallero, Emilio ^a,b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; TETRACYCLINE; BACTERIAL ANTIGEN; BACTERIAL DNA; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN; VIRULENCE FACTOR;

AGGLUTINATION TEST; ANTIBIOTIC SENSITIVITY; ARTHRITIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CELLULITIS; CLONE; CONTROLLED STUDY; FATALITY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHARYNGITIS; PULSED FIELD GEL ELECTROPHORESIS; SCARLET FEVER; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME; BACTERIAL MEMBRANE; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA SEQUENCE; EPIDEMIC; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; SEPTIC SHOCK; SEROTYPING; SPAIN; STREPTOCOCCUS INFECTION;

ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; PHARYNGITIS; SCARLET FEVER; SEQUENCE ANALYSIS, DNA; SEROTYPING; SHOCK, SEPTIC; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS;

EID: 77955188633     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-233     Document Type: Article

References (12)

1. Stollerman GH, Dale JB. The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin Infect Dis 2008, 46:1038-1045. 10.1086/529194, 18444821.
2. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci USA 1991, 88:8317-8321. 10.1073/pnas.88.19.8317, 52499, 1656437.
3. Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J, Kaplan EL, Musser JM, Hill HR. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 2004, 113:e168-e172. 10.1542/peds.113.3.e168, 14993572.
4. Erdem G, Mizumoto C, Esaki D, Reddy V, Kurahara D, Yamaga K, Abe L, Johnson D, Yamamoto K, Kaplan EL. Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States. Clin Infect Dis 2007, 45:e20-e24. 10.1086/519384, 17599299.
5. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalén C, Henriques-Normark B, Jasir A. Strep-EURO Study Group Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2009, 47:1155-1165. 10.1128/JCM.02155-08, 2668334, 19158266, Strep-EURO Study Group.
6. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C, . Active Bacterial Core Surveillance Team The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007, 45:853-862. 10.1086/521264, 17806049, Active Bacterial Core Surveillance Team.
7. Pérez-Trallero E, Montes M, Orden B, Tamayo E, García-Arenzana JM, Marimón JM. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother 2007, 51:1228-1233. 10.1128/AAC.01054-06, 1855467, 17242142.
8. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; 19th informational suplement. CLSI documents M100-S19 2009, Clinical and Laboratory Standards Institute.
9. Crater DL, van de Rijn I. Hyaluronic acid synthesis operon (has) expression in group A streptococci. J Biol Chem 1995, 270:18452-18458. 10.1074/jbc.270.31.18452, 7629171.
10. Bosch T, Riera M, Galmés M, Ramírez A, Albertí S. [Invassive infections caused by Group A streptococci: clinical characteristics and microbiological analyses in 31 cases]. Enferm Infecc Microbiol Clin 2001, 19:371-375.
11. Sierra JM, Sánchez F, Castro P, Salvadó M, de la Red G, Libois A, Almela M, March F, Español M, Sambeat MA, Romeu J, Brugal MT, García de Olalla P, Gatell JM, Vila J, García F, López Colomés JL, Caylá JA, Coll P. Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003. Medicine (Baltimore) 2006, 85:139-146. 10.1097/01.md.0000224707.24392.52, 16721256.
12. Weil-Olivier C. Rheumatic fever. Orphanet encyclopedia 2004, (read May 2010)., http://www.orpha.net/data/patho/GB/uk-RF.pdf